发明名称 Measurement of brain CDP-diacylglycerol synthase 1 enzyme and uses thereof
摘要 Provided herein are methods of diagnosing depressive disorders in a subject by comparing a CDP-diacylglycerol synthase 1 enzyme activity or expression level to enzyme activity or expression level of CDP-diacylglycerol synthase 1 in a control subject. Also herein are methods of predicting therapeutic efficacy of an antidepressant drug in a subject with depressive disorders by monitoring enzyme activity or expression level of CDP-diacylglycerol synthase 1 in the subject. Further provided herein are methods of identifying a compound effective to treat or alleviate the symptoms of depression by monitoring enzyme activity or expression level of CDP-diacylglycerol synthase 1 in a tissue. Further provided are kits for diagnosing depressive disorders.
申请公布号 US9593360(B2) 申请公布日期 2017.03.14
申请号 US201213626051 申请日期 2012.09.25
申请人 Undieh Ashiwel S 发明人 Undieh Ashiwel S
分类号 A61K31/135;A61K31/445;A61K31/47;C12Q1/25;A61K31/55;G01N33/68 主分类号 A61K31/135
代理机构 代理人 Adler Benjamin Aaron
主权项 1. A method of assessing and monitoring a depressive disorder in a test subject, comprising: obtaining a sample from the test subject and from a control subject; measuring an expression level of a CDP-diacylglycerol synthase 1 enzyme and of a CDP-diacylglycerol synthase 2 enzyme in the test sample and in the control sample; determining a ratio of the expression levels of the CDP-diacylglycerol synthase 1 enzyme to the CDP-diacylglycerol synthase 2 enzyme in the test sample and in the control sample; comparing the ratio of the expression levels in the test sample to the ratio of the expression levels in the control sample subject; assessing the test subject as having the depressive disorder when a statistically lower ratio is present in the test sample compared to the control sample; and monitoring said ratio in the test subject after an administration of an antidepressant drug to the test subject.
地址 Ellicott City MD US